Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
  1. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,748 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 2,077 shares (to pay taxes)
  3. 4 Exercise or conversion Chief Executive Officer acquired 10,966 shares (option exercise)
  4. 4 Exercise or conversion Chief Scientific Officer acquired 7,000 shares (option exercise)
  5. 4 Grant or award Chief Business Officer acquired 4,210 shares (grant or award)
  6. 4 Grant or award Chief Scientific Officer acquired 4,550 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 5,430 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 5,370 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 14,700 shares (grant or award)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 859 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 141,923 shares at an average $16.20 ($2,299,015)
  17. 4 Open-market buy Director bought 500,000 shares at $17.10 ($8,550,000)
  18. 4 Open-market sale Director sold 500,000 shares at $17.10 ($8,550,000)
  19. 4 Open-market buy Director bought 789,294 shares at an average $50.68 ($39,999,977)
  20. 4 Open-market buy Chief Financial Officer bought 4,617 shares at $54.14 ($249,964)

Page 3 of 12 · 226 filings